Evidence map›Paper›PMID 28759213›Full record

ArticleJournal of the American Chemical Society2017

Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog/Patched Interaction.

Andrew E Owens, Ivan de Paola, William A Hansen, Yi-Wen Liu, Sagar D Khare, Rudi Fasan

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Preparation of Bacterial Cell-Surface Displayed Semisynthetic Cyclic Peptides.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrew E OwensDepartment of Chemistry, University of Rochester , 120 Trustee Road, Rochester, New York 14627, United States.
Ivan de PaolaDepartment of Chemistry, University of Rochester , 120 Trustee Road, Rochester, New York 14627, United States.
William A HansenDepartment of Chemistry and Chemical Biology, Center for Integrative Proteomics Research, Rutgers University , 174 Frelinghuysen Road, Piscataway, New Jersey 08854, United States.
Yi-Wen LiuDepartment of Chemistry, University of Rochester , 120 Trustee Road, Rochester, New York 14627, United States.
Sagar D KhareDepartment of Chemistry and Chemical Biology, Center for Integrative Proteomics Research, Rutgers University , 174 Frelinghuysen Road, Piscataway, New Jersey 08854, United States.
Rudi FasanDepartment of Chemistry, University of Rochester , 120 Trustee Road, Rochester, New York 14627, United States.ORCID 0000-0003-4636-9578
University of Rochester · USRutgers, The State University of New Jersey · US

Funding

Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathwayR21CA187502 · NCI · UNIVERSITY OF ROCHESTER · PI FASAN, RUDI · 2014 to 2015
$367k
NCI NIH HHS R21 CA187502
6 · The paper itself

Abstract

The hedgehog (Hh) signaling pathway plays a central role during embryonic development, and its aberrant activation has been implicated in the development and progression of several human cancers. Major efforts toward the identification of chemical modulators of the hedgehog pathway have yielded several antagonists of the GPCR-like smoothened receptor. In contrast, potent inhibitors of the sonic hedgehog/patched interaction, the most upstream event in ligand-induced activation of this signaling pathway, have been elusive. To address this gap, a genetically encoded cyclic peptide was designed based on the sonic hedgehog (Shh)-binding loop of hedgehog-interacting protein (HHIP) and subjected to multiple rounds of affinity maturation through the screening of macrocyclic peptide libraries produced in E. coli cells. Using this approach, an optimized macrocyclic peptide inhibitor (HL2-m5) was obtained that binds Shh with a K

Indexed as

Drug DesignAnimalsCell LineHedgehog ProteinsHumansMacrocyclic CompoundsPeptidesSignal TransductionTranscription, GeneticHedgehog ProteinsMacrocyclic CompoundsPeptides

Identifiers

PMID28759213
PMCPMC5753398
OpenAlexW2740406078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.